跳至主要内容
临床试验/ACTRN12609000289213
ACTRN12609000289213已完成4 期

Ocular measures for detection of driving impairment due to sleep loss, alcohol and benzodiazepine use

Austin Health0 个研究点目标入组 32 人开始时间: 2009年5月18日最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
发起方
Austin Health
入组人数
32

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Prevention
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 50 Years(—)
性别
All

入选标准

  • healthy, drivers licence, alcohol intake in standard drinks >0 average <5/day for males and < 3/day for females

排除标准

  • 1.Epilepsy
  • 2.Diabetes requiring insulin
  • 3.Chronic psychiatric illness
  • 4.Visual impairment which does not correct with glasses
  • 5.Unable to speak and read English
  • 6.Drink more than 5 caffeinated beverages per day
  • 7.Significant daytime sleepiness (Epworth Sleepiness Scale score > 11).
  • 8.Chronic neurological illness
  • 9.Chronic liver disease, diabetes requiring insulin or renal impairment
  • 10.Pregnancy or breast feeding
  • 11.Sleep apnoea, narcolepsy
  • 12.Use of sedating medication
  • 13.Anticoagulation with warfarin

研究者

发起方
Austin Health

相似试验